EU approval for BMS's Orencia in combo with methotrexate to treat polyarticular juvenile idiopathic arthritis
Thursday, January 28, 2010 11:00 IST Paris
Bristol-Myers Squibb Company (BMS) announced that on 20 January 2010, the European Commission approved Orencia (abatacept) in combination with methotrexate for the treatment of moderate